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Recent publications inCell StemCell (Son et al., 2011; Ambasudhan et al., 2011), PNAS (Pfisterer et al., 2011),
and Nature (Caiazzo et al., 2011; Pang et al., 2011; Yoo et al., 2011) report that functional neurons can be
directly generated from human fibroblast cells without going through the pluripotent state.In 2006, Takahashi and Yamanaka re-
ported their groundbreakingworkshowing
that forced expression of four transcrip-
tion factors (Oct4, Sox2, Klf4, and c-Myc)
could revert fully differentiated somatic
tissues to embryonic stem cell (ESC)-like
pluripotent cells, so called ‘‘induced
pluripotent stem cells (iPSCs)’’ (Takahashi
andYamanaka,2006). Theirwork,and that
of others after them, opened the door to
the generation of patient-specific cells for
use in disease mechanism studies, drug
screening, and future personalized medi-
cine. At the same time, this cellular
alchemy emphasized that somatic cells
retain broad cellular plasticity that can
enable fate changes, under appropriate
circumstances, and raised the question
of whether directed transdifferentiation
might be a more tenable goal than previ-
ously imagined, for instance, beyond
germ layer boundaries. In this light,Wernig
and his colleagues demonstrated that
three neuronal lineage-inducing transcrip-
tion factors (Brn2, Ascl1, and Myt1l;
BAM) could efficiently convert meso-
dermal mouse fibroblasts into induced
neuronal cells (iNs) (Vierbuchen et al.,
2010). The resulting ectodermal neurons
displayed authentic functions such as
expressionof neuron-specificgenes, firing
of action potentials, and formation of
functional synapses. However, strangely,
the majority of iN cells resembled cortical
neurons and exhibited excitatory traits.
In contrast, GABAergic neurons were
sparse and other neurotransmitter types
(like DA neurons) were undetectable, sug-
gesting that additional factors may be
necessary for conversion to diverse neu-
ronal subtypes. Furthermore, it is unclear
whether the same recipe can convert
human cells into iNs.Now, six independent groups demon-
strate that varied combinations of factors
can indeed convert human fibroblasts
not only into human iNs (hiNs), but also
into specific neuronal subtypes such as
dopamine (hiDAs) and motor neurons
(hiMNs) (Table 1). First, Pfisterer et al.
(2011) tested the same BAM factors
and found that both embryonic and post-
natal human fibroblasts can be converted
into hiNs with reported efficiencies of
approximately 16%and 4%, respectively.
While these hiNs remained immature at
23 days after conversion, they exhibited
the electrophysiological properties of
mature neurons after 30–32 days in cul-
ture. Similar to mouse iNs induced by the
same three factors (Vierbuchen et al.,
2010), these hiNs were predominantly
glutamatergic and rarely GABAergic, but
no other phenotypes such as DA neurons
were apparent. Thus, the authors ex-
tended their approach to include a panel
of lineage-specific genes involved in
midbrain DA neuron development, and
found that the addition of two factors
(Lmx1a and FoxA2) to the BAM factors
was optimal for generating hiDAs (10%
of hiNs). These hiDAs expressed other
midbrain markers and generated sponta-
neous action potentials, both indicative
of midbrain DA neurons. Wernig and
colleagues also extended their original
findings and tested the same BAM factors
in human cells. They observed that human
fetal fibroblasts were converted into
immature neuronal cells within 20 days
of transgene expression (Pang et al.,
2011). Subsequently, they screened 20
additional factors, focusing on general
neuronal induction rather than DA-lineage
induction, and found that the addition of
NeuroD1 (BAMN) improved the genera-Cell Stem Cell 9, Stion of Tuj1+ neuronal cells. Interestingly,
the BAMN factors induced hiN genera-
tion from fetal and postnatal fibroblasts
with similar efficiencies (2%–4% of cells
plated). These BAMN-iNs showed mature
neuronal morphology, expressed pan-
neuronal genes, generated action poten-
tials, and formed synaptic contacts.
Furthermore, Fluidigm dynamic RT-PCR
analysis of single hiNs showed that
approximately 10% (5 out of 54 cells)
were positive for tyrosine hydroxylase
(TH), indicating that they might be dopa-
minergic. Caiazzo et al. (2011) designed
a strategy to more directly promote the
DA neuron fate by using combinations
of inducible lentiviruses expressing the
BAM cocktail with 11 DA-inducing factors
to transduce mouse embryonic fibro-
blasts from TH-GFP transgenic mice, re-
sulting in bright GFP+ reprogrammed
cells. By varying the factors used, the
authors found that the combination of
Mash1/Nurr1/Lmx1a induces GFP+ cells
with up to 18% efficiency. Remarkably,
the majority of induced Tuj1+ cells (85%)
were GFP+/TH+ and exhibited functional
DA neuronal phenotypes, such as expres-
sion of midbrain DA neuron markers,
electrophysiological properties, and con-
trolled DA uptake. Furthermore, the
same recipe efficiently converted human
fetal fibroblasts to Tuj1+ and TH+ neu-
ronal cells. Finally, this procedure was
used to derive hiNs and hiDAs from the
fibroblasts of Parkinson’s disease (PD)
patients and healthy adult donors. These
hiDAs coexpressed multiple midbrain DA
markers, showed typical electrophysio-
logical properties, and showed depolar-
ization-induced DA release. Together,
these studies demonstrate that it is
indeed possible to generate functionaleptember 2, 2011 ª2011 Elsevier Inc. 179
Table 1. Conversion of Human Fibroblasts into Functional Neurons
Starting Cells Transgenes Method Readout Reference
MEF, MPF Brn2, Ascl1, Myt1l (BAM) i-lentivirus iN (1.8%–7.7%) Vierbuchen et al., 2010
HEF, HPF BAM, NeuroD1 i-lentivirus hiN (2%–4%) Pang et al., 2011
HEF; HPF BAM, FoxA2, Lmx1A i-lentivirus hiN (4%–16%); hiDA (10% of hiN) Pfisterer et al., 2011
MEF; HEF; HAF Ascl1, Nurr1, Lmx1A i-lentivirus iDA (18%); hiN (10%), hiDA (6%);
hiN (5%), hiDA (3%)
Caiazzo et al., 2011
HPF; HAF miR-9/9*, miR-124, Ascl1, Myt1l, NeuroD2 lentivirus hiN (10%); hiN Yoo et al., 2011
HPF miR-124, Brn2, Myt1l i-lentivirus hiN (4%–8%) Ambasudhan et al., 2011
MEF; HEF BAM, Lhx3, Hb9, Isl1, Ngn2; BAM,
Lhx3, Hb9, Isl1, Ngn2, NeuroD1
retrovirus iMN (5%–10%); hiMN Son et al., 2011
Abbreviations: MEF, mouse embryonic fibroblasts; MPF, mouse postnatal fibroblasts; HEF, human embryonic fibroblasts; HPF, human postnatal
fibroblasts; HAF, human adult fibroblasts; i-lentivirus, inducible lentivirus; iN, induced neurons; hiN, human induced neurons; iDA, induced dopamine
neurons; iMN, induced motor neuron. Readout percentages reflect reported efficiencies of conversion.
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PreviewshiNs and hiDAs directly from human fibro-
blasts, even from adult patients’ tissues.
Based on their previous studies show-
ing that miR-9* and miR-124 critically
regulate neuronal differentiation through
compositional changes of SWI/SNF-
like BAF chromatin-remodeling complex,
Gerald Crabtree and his colleagues ad-
dressed whether expression of these
miRNAs can convert human fibroblasts
into neurons. Remarkably, forced expres-
sion of miR-9* and miR-124 in a single
lentiviral vector could convert human
fibroblasts to hiNs, which was greatly
facilitated by a neurogenic transcription
factor NeuroD2 (Yoo et al., 2011). Further
addition of Ascl1 and Myt1l enhanced the
reported efficiency up to 5% of the
starting cells, although no hiDAs were
detected. This recipe could also convert
adult human fibroblasts into functioning
neurons. In addition, Sheng Ding and his
colleagues combined miR-124 and two
transcription factors, Brn2 and Myt1l, to
directly convert both postnatal and adult
human fibroblasts into functional neurons
with similar efficiencies, as evidenced
by mature neuronal morphology, marker
gene expression, action potential firing,
and functional synapse formation (Amba-
sudhan et al., 2011). Notably, this method
yielded many GABA and glutamatergic
neurons, but DA and serotonin neurons
were rare or undetectable, suggesting
that lineage-specific factors may be
required to guide the conversion to these
cell fates.
Finally, in this issue of Cell Stem Cell,
Kevin Eggan and colleagues report that
forced expression of select transcription
factors can convert mouse and human
fibroblasts into functional induced motor180 Cell Stem Cell 9, September 2, 2011 ª20neurons (iMNs) (Son et al., 2011). They
used a similar strategy as those described
above, and tested different combinations
of the BAM factors with known motor
neuron specification factors, using em-
bryonic fibroblasts from an Hb9::GFP
mouse tomonitor the conversion to motor
neurons. They determined an optimal
combination of seven factors (Table 1),
which allowed efficient conversion of
mouse embryonic fibroblasts (5%–10%)
to iMNs that exhibited typical mor-
phology, gene expression patterns, elec-
trophysiological and synaptic properties,
and even in vivo engraftment capacity,
similar to that seen using embryo-derived
motor neurons. In addition, these MNs
showed both cell-autonomous and non-
autonomous sensitivities to degenerative
stimuli, strongly suggesting that these
iMNs would be useful for studying motor
neuron disease (e.g., ALS) mechanisms.
The authors also successfully applied
their seven-factor cocktail, with NeuroD1,
to convert human embryonic fibroblasts
into functional, cholinergic hiMNs.
Collectively, these studies further
advance this fast-moving field, and
demonstrate that direct cell fate conver-
sion, or transdifferentiation, can be used
to generate diverse hiNs that include
hiDA, hiMN, and glutamatergic neurons
for use in disease mechanism studies,
and potentially for future cell replacement
therapies. However, this field is still in
its infancy and there are many issues
to be overcome. Most importantly, the
molecular and/or epigenetic mechanisms
underlying these cell fate changes remain
to be elucidated. For example, it is
intriguing that significantly different com-
binations of transgenes and/or miRNAs11 Elsevier Inc.synergistically or sometimes antagonisti-
cally lead to a distinct neuronal cell fate
or fates. It remains to be seen whether
these hiNs have acquired a long-term
sustainable genetic program that will
function both in vitro and in vivo. Further-
more, the identification of additional
factors (e.g., general neuronal induction
factors, specific lineage factors, and
noncoding RNAs) and their optimal stoi-
chiometric and kinetic combinations will
likely improve the efficiency of specific
neuronal conversion. Notably, in another
study, Sheng Ding and his colleagues
elegantly showed that transient expres-
sion of the four reprogramming factors
efficiently reprogrammed mouse fibro-
blasts into neuronal progenitors that
could proliferate and then differentiate
into functional neurons, including DA
neurons (Kim et al., 2011). While the direct
conversion strategy discussed above
appears to bypass the pluripotent/multi-
potent stem cell stages and thus may
avoid the potential risk of tumor forma-
tion, it can also limit the final number of
cells that can be obtained. Thus, the
potential to extend the findings of Kim
et al. (2011) to the conversion of human
fibroblasts into expandable progenitors
with minimal or no risk of tumor formation
is very attractive, and should be pursued.
Also, while the direct conversion studies
used human fibroblasts as the starting
material, it remains to be seen whether
hiNs can be similarly generated from
alternate cell types (e.g., lymphocytes).
Last but not least, in light of recent find-
ings that significant numbers of gene
mutations and copy number variants can
be induced during reprogramming (Barril-
leaux and Knoepfler, 2011), it will be
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Previewscritical to develop nonviral, genome non-
integrating conversion methods such as
direct protein delivery (Kim et al., 2009).REFERENCES
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The forkhead box O (FoxO) family is involved in diverse cellular processes such as tumor suppression, stress
response, and metabolism. In a recent Nature Cell Biology Letter, Zhang et al. (2011) uncover a novel role for
FoxO proteins in regulating the identity of human ESCs.Embryonic stem cells (ESCs) are distin-
guished by the features of pluripotency
(the ability to give rise to all cell types in
and derived from the embryo proper) and
self-renewal (the capability to be grown
indefinitely in an undifferentiated state
in vitro). This unique ESC state is defined
by a distinct gene expression profile
crafted by the ESC transcription network,
wherein the trio of OCT4, SOX2, and
NANOG lies at the core (reviewed in
Young, 2011). The ESC state is nonethe-
less sustainedbymanyother transcription
factors, establishing an integrated tran-
scription network,which,whenperturbed,
triggers the loss of ESC identity.
The extended pluripotency network
includesnumerous familiesof transcription
factors, including the Kru¨ppel-like tran-
scription factors, orphan nuclear recep-
tors, the Myc transcription factor cluster,
SMAD proteins, and PR domain-contain-
ing transcriptional regulators to highlighta few (reviewed in Gonzales and Ng,
2011). In a recent issue of Nature Cell
Biology, Ghaffari and colleagues (Zhang
et al., 2011) introduce a new component
to this network of pluripotency regulators:
the forkheadboxO (FoxO) family (Figure1).
FoxO proteins are transcription factors
thatactasstress-response tumorsuppres-
sors byblocking cell cycle progression and
inducing apoptosis (reviewed in van den
Berg and Burgering, 2011). FoxO proteins
also induce expression of enzymes
involved in protection fromoxidative stress
and are important for metabolic processes
in liver and muscle cells.
Despite the wide scope of function of
the FoxO family throughout the body, its
role in early embryonic development had
not yet been studied in detail. In this
respect, Ghaffari and colleagues have
found that FOXO1 is expressed at abun-
dant levels in both mouse ESCs (mESCs)
and human ESCs (hESCs) and is depletedduring differentiation (Zhang et al., 2011).
For assessing the functional relevance of
FOXO1 in hESCs, a short hairpin RNA
(shRNA)-mediated knockdown experi-
ment was performed. They observed the
acquisition of an epithelial flattened
morphology accompanied by a loss of
pluripotency markers and an increase in
endomesoderm markers. This phenotype
can be rescued by immediate FOXO1
overexpression, demonstrating the speci-
ficity of the shRNA knockdown. How-
ever, when hESCs were cultured under
FOXO1 knockdown conditions for a few
passages, the rescue did not work.
This finding indicates that FOXO1 deple-
tion can trigger irreversible differentiation
within several passages, emphasizing the
importance of FOXO1 in ESCs.
Interestingly, differences were ob-
served between mouse and human
ESCs in the role of FOXO3A/Foxo3,
another FoxO family member tested ineptember 2, 2011 ª2011 Elsevier Inc. 181
